Position
Creative Planning in Phathom Pharmaceuticals, Inc.
Back to the book · All holders of PHAT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$384.7K$16.59 → $11.11
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 80.8K | $1.34M | — | — | — | 0.0% |
| Q1 2026 | 70.2K | $779.8K | $11.11 | −$384.7K | −$175.4K | 0.0% |